Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 6.16 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 6.9 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 6.77 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 6.7 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 8.72 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 6.84 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 4.64 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 2.04 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 0.0 | BCD100427B001 | 5.55 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 0.5 | BCD100427B003 | 4.69 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 1.0 | BCD100427B007 | 5.69 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 2.0 | BCD100427B011 | 5.63 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 4.0 | BCD100427B015 | 5.95 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 8.0 | BCD100427B019 | 5.61 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 12.0 | BCD100427B023 | 4.85 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 24.0 | BCD100427B027 | 2.91 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 9.75 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 5.74 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 8.22 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 7.75 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 4.32 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 3.37 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 1.99 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 0.5 | BCD100427B004 | 7.28 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 1.0 | BCD100427B008 | 6.36 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 2.0 | BCD100427B012 | 6.48 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 4.0 | BCD100427B016 | 7.01 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 8.0 | BCD100427B020 | 4.66 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 12.0 | BCD100427B024 | 3.43 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 24.0 | BCD100427B028 | 1.82 | pmol/sample |